Sidra Medicine, a member of Qatar Foundation, has launched a new specialized Microbiome Service.
The service will provide access to advanced microbiome testing and analysis to support precision medicine, clinical research, and personalized healthcare for women, children, and young people.
According to the statement, combining cutting-edge sequencing technologies with multidisciplinary research expertise, the private-paid service will be provided to academic and industry investigators. It will help identify the role of the human microbiome in health and disease.
By analyzing the complex communities of microorganisms that naturally inhabit the body, the service supports clinicians and researchers in advancing diagnosis, treatment strategies, and disease prevention across a range of conditions.
Building on this momentum, Sidra Medicine has announced that it will be hosting its second MENA Microbiome Conference from October 17 to 18.
The launch of the Microbiome Service reflects Sidra Medicine’s continued commitment to advancing precision medicine and strengthening its focus on translational research that bridges scientific discovery with clinical application. The initiative is designed to enhance understanding of the human microbiome and its role in health and disease, enabling more targeted and personalized approaches to diagnosis, prevention, and treatment.
It also reinforces Qatar’s growing position as a regional hub for scientific innovation and personalized healthcare, supporting the development of advanced medical capabilities and fostering research-driven healthcare solutions. Through this initiative, Sidra Medicine continues to contribute to the expansion of cutting-edge biomedical research and the delivery of more individualized, data-driven patient care.
As per the statement, the service was launched by the Laboratory of Microbiome and Biomarkers Discovery to support researchers, particularly in the MENA region, who either lack the expertise or the infrastructure to process their samples.
